by Maurice Michel | 21 Sep, 2016 | Clinical testing, MTH1, Short news |
The Helleday Team proudly presents our new potent MTH1 inhibitor Karonudib, which is 20 times more effective than the previously described TH588 inhibitor, recently published in Annals of Oncology. Karonudib stands for: Karolinska nudt1 (MTH1 gene name) inhibitor. In...
Recent Comments